功能动态网络连接区分了阿尔茨海默病连续体中的生物模式
Lorenzo Pini1, Lorenza Brusini2, Alessandra Griffa3
1Padova Neuroscience Center, University of Padova, Via Giuseppe Orus 2/B, 35131 Padova, Italy; Department of Neuroscience, University of Padova, via Belzoni 160, 35121 Padova, Italy.
Neurobiology of disease
|March 13, 2025
概括
阿尔茨海默病是一种网络综合征. 大脑连接模式揭示了患者的独特生物学特征,有助于识别各种阿尔茨海默氏症病理.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 越来越多地被视为一种基于网络的综合症.
- 网络异常与粉样β和积等分子标志相关,导致神经退行.
- 了解分子病理学和大脑网络动态之间的相互作用对于AD诊断至关重要.
研究的目的:
- 调查阿尔茨海默病 (AD) 的独特生物模式是否与大脑动态连接的特定异常保持一致.
- 将分子数据与静止状态功能磁共振成像 (rs-fMRI) 结合起来,以识别患者群.
- 探索宏观网络变化与AD分子病理学之间的关系.
主要方法:
- 利用数据驱动的方法,根据生物模式识别患者集群.
- 使用休息状态功能磁共振成像 (rs-fMRI) 来评估大脑动态连接.
- 结合 rs-fMRI 数据与分子标记物 (粉样β,,神经退行) 进行综合分析.
主要成果:
- 确定了三个不同的患者群,病理变化程度和临床表现各不相同.
- 发现了两个关键的连接模式在默认模式网络和 occipito-temporal皮质,与典型和非典型的AD形状相关.
- 发现动态连接标记可以区分AD患者具有相似的临床特征,但不同的潜在病理.
结论:
- 宏观大脑网络的改变从根本上与阿尔茨海默病中的分子变化有关.
- 动态功能连接分析提供了一个有价值的工具,用于识别具有明显病理基础的AD患者子组.
- 这种方法可以帮助个性化诊断和阿尔茨海默病的治疗策略.
相关概念视频
Alzheimer's Disease: Overview
409
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
409
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Dementia
82
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
82
Alzheimer's Disease: Treatment
141
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
141


